STOCK TITAN

Surgery Partners (SGRY) Stock News

SGRY NASDAQ

Surgery Partners, Inc. reports developments tied to its short-stay surgical facility network and outpatient delivery model. The company provides surgical and related ancillary care through ambulatory surgery centers, surgical hospitals, anesthesia services, multi-specialty physician practices and urgent care facilities, with revenue tied to patient care services and facility case activity.

Recurring SGRY news includes quarterly results, same-facility revenue and case trends, adjusted EBITDA and guidance, operational initiatives, portfolio optimization, acquisition activity, financing and leverage actions, share repurchase authorizations, board composition and shareholder communications involving the company’s strategic direction.

Rhea-AI Summary

Surgery Partners (SGRY) launched a consent solicitation through Surgery Center Holdings to amend terms governing $1.225 billion of senior notes. The 7.250% notes due 2032 would recognize Bon Secours Mercy Health, HealthSpan Partners and specified related parties as permitted holders in connection with the planned Spyglass Topco merger. Without operative amendments, closing would require an offer to repurchase the notes at 101% of principal, plus accrued and unpaid interest.

Consents are due November 20, 2026, at 5:00 p.m. New York City time, unless extended or terminated earlier. Eligible consenting holders would receive $2.50 per $1,000 principal, subject to conditions. A majority of outstanding principal must consent. Principal, interest rate and maturity remain unchanged. Surgery Partners expects the merger to close in the first quarter of 2027, subject to stockholder and regulatory approvals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Surgery Partners (NASDAQ:SGRY) reported third-quarter 2026 revenue of $815.3 million, down 0.8% from the same period a year earlier. Same-facility revenue rose 6.0%. The attributable net loss narrowed to $21.1 million from $22.7 million, while adjusted EBITDA fell to $132.7 million from $136.4 million. Results include ownership of the Idaho Falls facilities through September 13, 2026.

An amended merger agreement with HealthSpan Partners raises consideration to $25.00 per share in cash, representing enterprise value of up to approximately $6.0 billion. Eligible holders receive conditional monthly payments if closing slips beyond March 1, 2027. The company expects closing in the first quarter of 2027, subject to stockholder and regulatory approvals. Surgery Partners will no longer provide forward-looking guidance. Nine-month revenue rose 2.1% to $2,475.1 million; its attributable net loss widened to $72.0 million from $62.9 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.06%
Tags
-
Rhea-AI Summary

Surgery Partners (NASDAQ: SGRY) amended its merger agreement with HealthSpan Partners, increasing the cash consideration to $25.00 per share. Non-Bain stockholders may also receive ticking fees if stockholder approval is obtained but closing has not occurred by March 1, 2027. With approval before that date and closing on October 23, 2027, fees reach up to $1.61 per share, bringing maximum consideration to $26.61 and enterprise value to up to approximately $6.0 billion.

The board approved the amendment after evaluating a non-binding $28.00-per-share competing cash proposal, which the independent special committee determined was not superior. Bain Capital will roll over its shares rather than receive cash. Closing remains expected in the first quarter of 2027, subject to stockholder and regulatory approvals and other customary conditions. The board recommends stockholders approve the amended merger.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.01%
Tags
Rhea-AI Summary

Surgery Partners (NASDAQ:SGRY) agreed to an acquisition by HealthSpan Partners in an all-cash transaction valued at approximately $5.7 billion in enterprise value. Shareholders other than Bain Capital affiliates will receive $23.50 per share. Bain affiliates will exchange their shares for equity in the acquiring entity and remain a partner after closing.

Closing is expected in the first quarter of 2027, subject to shareholder and regulatory approvals. The board approved the deal following an independent special committee’s unanimous recommendation. Bain, which owns approximately 39% of outstanding shares, agreed to vote its shares in favor. HealthSpan intends to fund the acquisition with cash on hand and new debt backed by secured commitments. After completion, Surgery Partners will become privately held and leave Nasdaq; its name, brand and headquarters are expected to remain in place.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
47.62%
Tags
-
Rhea-AI Summary

Surgery Partners (SGRY) has closed the sale of its ownership interests in the Idaho Falls facilities, including Mountain View Hospital and Idaho Falls Community Hospital, to Intermountain Health for approximately $1.15 billion in facility value, receiving $797 million in gross proceeds and $587 million in net cash at closing.

The consideration reflects about a 7x multiple of the Idaho Falls facilities’ last‑12‑months adjusted EBITDA through June 30, 2026, and an approximately 17x multiple of average distributions over the past three years. Transaction proceeds will be used primarily to pay down debt, with balance sheet leverage expected to improve by 30 basis points from 4.4x at the end of Q2 2026. Updated full‑year 2026 guidance now calls for revenue of $3.08–$3.18 billion and at least $489 million of adjusted EBITDA, with pro forma guidance excluding Idaho Falls of $2.60–$2.67 billion of revenue and at least $414 million of adjusted EBITDA.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.16%
Tags
none
-
Rhea-AI Summary

Surgery Partners (NASDAQ: SGRY) reported second quarter 2026 revenue of $848.9 million, up 2.7% year over year, with same-facility revenue up 5.0% on a 4.8% increase in revenue per case and 0.3% higher same-facility cases. Adjusted EBITDA was $125.2 million, down from $129.0 million, and net loss attributable to Surgery Partners widened to $15.0 million from $2.5 million, or a basic and diluted loss per share of $0.12.

Year-to-date 2026 revenue rose 3.6% to $1,659.8 million, with Adjusted EBITDA of $227.5 million versus $232.9 million. The company reaffirmed full-year 2026 guidance for revenue of $3.35–$3.45 billion and Adjusted EBITDA of at least $530 million, excluding the impact of the pending Idaho Falls divestiture. Liquidity at June 30, 2026 included $216.7 million of cash and $617.8 million of revolver capacity, with net debt-to-EBITDA at approximately 4.4x.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.70%
Tags
Rhea-AI Summary

Surgery Partners (NASDAQ:SGRY) and its partner Intermountain Health have placed into escrow signed pages to definitive agreements under which Surgery Partners would sell its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health. Physician ownership of Mountain View Hospital would remain unchanged.

The combined Idaho Falls facilities are valued at approximately $1.15 billion, with total consideration to Surgery Partners of about $795 million, subject to customary purchase price adjustments. Closing is contingent on Mountain View physician approvals, regulatory clearances (including Hart-Scott-Rodino) and other consents, and there is no assurance the transaction will complete. Excluding any impact from this deal, the company reaffirmed its 2026 guidance for revenues of $3.35–$3.45 billion and Adjusted EBITDA of at least $530 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.35%
Tags
none
-
Rhea-AI Summary

Surgery Partners (NASDAQ:SGRY) reported first quarter 2026 results for the period ended March 31, 2026. Revenue was $810.9 million, up 4.5% year-over-year; adjusted EBITDA was $102.3 million; net loss attributable to Surgery Partners was $35.9 million. The company reaffirmed 2026 guidance: revenue of $3.35B–$3.45B and adjusted EBITDA of at least $530 million. Cash and equivalents were $182.3 million and revolving credit capacity was $666.1 million. The company will host a conference call on May 5, 2026 at 8:30 a.m. ET.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.42%
Tags
-
Rhea-AI Summary

Surgery Partners (NASDAQ:SGRY) will release first quarter 2026 results before the market opens on Tuesday, May 5, 2026, followed by a conference call at 8:30 a.m. ET. Live dial-in numbers, replay details and a webcast on the company's Investor Relations website are provided.

The replay will be available until May 19, 2026, and the company posts financial and material information on its website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.24%
Tags
conferences earnings date
Rhea-AI Summary

Surgery Partners (NASDAQ:SGRY) appointed Lloyd Dean to its Board of Directors on March 12, 2026. Mr. Dean is a former CEO of CommonSpirit Health and Dignity Health, a healthcare adviser to federal administrations, and currently serves on multiple corporate boards and as a Bain Capital senior advisor.

This addition brings national health system leadership experience aimed at supporting Surgery Partners' expansion of high‑value outpatient surgical care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.83%
Tags
management

FAQ

What is the current stock price of Surgery Partners (SGRY)?

Surgery Partners (SGRY) last closed at $26.95.

What is the market cap of Surgery Partners (SGRY)?

The market cap of Surgery Partners (SGRY) is approximately $3.5B.